000 01219 a2200361 4500
005 20250516040424.0
264 0 _c20111219
008 201112s 0 0 chi d
022 _a0578-1426
040 _aNLM
_beng
_cNLM
100 1 _aZhang, Qing-yi
245 0 0 _a[The efficacy and safety of valproic acid in combination with low dose chemotherapy on intermediate and high-risk myelodysplastic syndrome].
_h[electronic resource]
260 _bZhonghua nei ke za zhi
_cMar 2011
300 _a240-2 p.
_bdigital
500 _aPublication Type: Controlled Clinical Trial; English Abstract; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMyelodysplastic Syndromes
_xdrug therapy
650 0 4 _aRetrospective Studies
650 0 4 _aValproic Acid
_xadministration & dosage
700 1 _aGe, Gui-min
700 1 _aYan, Yi-peng
700 1 _aHan, Xiao-lin
700 1 _aHuang, Yan
700 1 _aWu, Sun
700 1 _aHe, Li-shan
773 0 _tZhonghua nei ke za zhi
_gvol. 50
_gno. 3
_gp. 240-2
999 _c20861875
_d20861875